Instituto Nacional de la Nutrición Salvador Zubiran Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00760032
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Gastroenterology, INCMNSZ | Florencia Vargas-Vorackova | Head Dept Nephrology and Mineral Metabolism National Medical Science and Nutrition Institute Salvador Zubiran MEXICO | Insituto Nacional de Nutricion de Ciencias Medicas y Nutricion Salvador Zubiran | Instituto Nacional de Ciencias Medicas y Nitrición Salvador Zubiran (INCMNSZ) | Instituto Nacional de Ciencias Médicas y Nutrición | Janette Furuzawa Carballeda | National Medical Science and Nutrition Institute Salvador Zubiran

Active Ingredients

Drugs in Phase 4 Trials (3)

ciprofloxacin (cipro) (1 trial)

isoniazid (nydrazid) (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 1 Trials (1)

collagen (1 trial)

Drugs in Other Trials (2)

maraviroc (selzentry) (1 trial)

spironolactone (aldactone) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Ascites (Phase 4)

Coinfection (Phase 4)

Communicable Diseases (Phase 4)

Fibrosis (Phase 4)

HIV Infections (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Infections (Phase 4)

Kidney Failure, Chronic (Phase 4)

Latent Tuberculosis (Phase 4)

Pulmonary Fibrosis (Phase 1)

Renal Insufficiency (Phase 4)

Tuberculosis (Phase 4)

Vascular Calcification (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6